share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 6 04:56
Summary by Moomoo AI
歌禮製藥有限公司（歌禮制药-B）於2024年2月6日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年2月6日期間，進行了多次股份購回活動，但並未註銷這些股份。在最後一次購回中，公司於2024年2月6日購回了1,500,000股普通股，佔已發行股份的0.1436%。該次購回的最高價格為每股1.64港元，最低價格為每股1.56港元，總共支付了2,441,190港元。自普通決議案通過以來，公司在香港聯交所購回的股份總數達到65,121,000股，佔當時已發行股份的5.9902%。公司確認，所有購回活動均按照香港聯交所的規定進行，並且已收取全部應得款項，符合上市規則的所有要求。
歌禮製藥有限公司（歌禮制药-B）於2024年2月6日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年2月6日期間，進行了多次股份購回活動，但並未註銷這些股份。在最後一次購回中，公司於2024年2月6日購回了1,500,000股普通股，佔已發行股份的0.1436%。該次購回的最高價格為每股1.64港元，最低價格為每股1.56港元，總共支付了2,441,190港元。自普通決議案通過以來，公司在香港聯交所購回的股份總數達到65,121,000股，佔當時已發行股份的5.9902%。公司確認，所有購回活動均按照香港聯交所的規定進行，並且已收取全部應得款項，符合上市規則的所有要求。
ACORN PHARMACEUTICALS CO., LTD. (CHANEL PHARMACEUTICALS-B) FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 6 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 6, 2024, but did not write them off. In the last repurchase, the company repurchased 1,500,000 shares of ordinary shares on February 6, 2024, representing 0.1436% of the issued shares. The highest price of the repurchase was HK$1.64 per share and the lowest price was HK$1.56 per share, with a total payment of HK$2,441,190. Since the adoption of the Ordinary Resolution, the total number of shares repurchased on the Hong Kong Stock Exchange has reached 65,121,000 shares, representing 5.9902% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the rules of the HKEx and that all monies due have been received, in accordance with all the requirements of the Listing Rules.
ACORN PHARMACEUTICALS CO., LTD. (CHANEL PHARMACEUTICALS-B) FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 6 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 6, 2024, but did not write them off. In the last repurchase, the company repurchased 1,500,000 shares of ordinary shares on February 6, 2024, representing 0.1436% of the issued shares. The highest price of the repurchase was HK$1.64 per share and the lowest price was HK$1.56 per share, with a total payment of HK$2,441,190. Since the adoption of the Ordinary Resolution, the total number of shares repurchased on the Hong Kong Stock Exchange has reached 65,121,000 shares, representing 5.9902% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the rules of the HKEx and that all monies due have been received, in accordance with all the requirements of the Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more